Catherine A. Byrnes

Apr 10, 2024 | err.ersjournals.com | Catherine A. Byrnes |Andrew Bush |Kate Chan |Anne B. Chang

IntroductionAll children have intermittent respiratory symptoms, many of which do not have immediate economic impact meaning that unfortunately, they are often not taken seriously. This is even though they may be a harbinger of future COPD [1], adult bronchiectasis [2], and early morbidity and mortality from respiratory and all-cause disease [3].

Mar 1, 2024 | openres.ersjournals.com | Catherine A. Byrnes |O'Byrne PM |Godard PP |Mark C. Holliday

MethodsThe STep-wise Anti-inflammatory Reliever Therapy Children's Asthma Research (START CARE) study is an investigator-initiated, 52-week, multicentre, open-label, parallel group, phase III, two-sided superiority randomised controlled trial (RCT) based in New Zealand (figure 1). The Medical Research Institute of New Zealand (MRINZ) is the sponsor of the study, which is conducted with support from AstraZeneca Ltd., by both supply of randomised medications and funding of the study.

Jul 20, 2023 | thelancet.com | Catherine A. Byrnes |Peter McIntyre |Emma Best

Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.